title: Therapy-related leukemia cutis with histopathologic changes resembling xanthogranuloma.
authors.affiliation: Department of Dermatology, Mackay Memorial Hospital, Taipei, Taiwan; Mackay Medicine, Nursing and Management College, Taipei, Taiwan.
authors.forename: Pa-Fan
authors.initials: PF
authors.lastname: Hsiao
authors.affiliation: Department of Hematology, Mackay Memorial Hospital, Taipei, Taiwan; Mackay Medicine, Nursing and Management College, Taipei, Taiwan.
authors.forename: Johnson
authors.initials: J
authors.lastname: Lin
authors.affiliation: Department of Dermatology, Mackay Memorial Hospital, Taipei, Taiwan; Mackay Medicine, Nursing and Management College, Taipei, Taiwan. Electronic address: yuhung_wu@yahoo.com.
authors.forename: Yu-Hung
authors.initials: YH
authors.lastname: Wu
mesh_terms: D000328:Adult; D001707:Biopsy, Needle; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006099:Granuloma / Q000175:diagnosis / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D007951:Leukemia, Myeloid / Q000139:chemically induced*; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000473:pathology; D017254:Leukemic Infiltration / Q000473:pathology; D016399:Lymphoma, T-Cell / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D014973:Xanthomatosis / Q000175:diagnosis / Q000473:pathology*
chemical_list: D003561:Cytarabine